Agreement between 2017 ACC/AHA Hypertension Clinical Practice Guidelines and Seventh Report of the Joint National Committee Guidelines to Estimate Prevalence of Postmenopausal Hypertension in a Rural Area of Bangladesh: A Cross Sectional Study
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Data Collection and Measurement
2.3. Blood Pressure Measurement and Definition of HTN
2.4. Ethical Consideration
2.5. Data Processing and Analysis
3. Results
3.1. Charactiristics of the Study Population
3.2. Prevalence of Postmenopausal HTN
3.3. Agreement between 2017 ACC/AHA and JNC 7 Guidelines
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Kearney, P.; Whelton, M.; Reynolds, K.; Muntner, P.; Whelton, P.; He, J. Global burden of hypertension: analysis of worldwide data. The Lancet 2005, 365, 217–223. [Google Scholar] [CrossRef]
- Lim, S.S.; Vos, T.; Flaxman, A.D.; Danaei, G.; Shibuya, K.; Adair-Rohani, H.; Amann, M.; Anderson, H.R.; Andrews, K.G.; Aryee, M.; et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: A systematic analysis for the Global Burden of Disease Study 2010. The Lancet 2012, 380, 2224–2260. [Google Scholar] [CrossRef]
- Khanam, M.A.; Lindeboom, W.; Koehlmoos, T.L.P.; Alam, D.S.; Niessen, L.; Milton, A.H. Hypertension: Adherence to treatment in rural Bangladesh—Findings from a population-based study. Glob. Health. Action 2014, 7, 25028. [Google Scholar] [CrossRef] [PubMed]
- Chobanian, A.; Bakris, G.; Black, H. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. The JNC 7 report. ACC Curr. J. Rev. 2003, 12, 31–32. [Google Scholar] [CrossRef]
- Zaman, M.M.; Bhuiyan, M.R.; Karim, M.N.; Moniruz, Z.; Rahman, M.M.; Akanda, A.W.; Fernando, T. Clustering of non-communicable diseases risk factors in Bangladeshi adults: An analysis of STEPS survey 2013. BMC Public Health 2015, 15, 659. [Google Scholar] [CrossRef]
- NCDs|STEPwise Approach to Chronic Disease Risk Factor Surveillance. World Health Organization 2017. Available online: http://www.who.int/chp/steps/bangladesh/en/ (accessed on 8 May 2019).
- Hill, K. The demography of menopause. Maturitas 1996, 23, 113–127. [Google Scholar] [CrossRef]
- Ong, K.L.; Tso, A.W.; Lam, K.S.; Cheung, B.M. Gender Difference in Blood Pressure Control and Cardiovascular Risk Factors in Americans With Diagnosed Hypertension. Hypertension 2008, 51, 1142–1148. [Google Scholar] [CrossRef] [Green Version]
- Burt, V.L.; Whelton, P.; Roccella, E.J.; Brown, C.; Cutler, J.A.; Higgins, M.; Horan, M.J.; Labarthe, D. Prevalence of Hypertension in the US Adult Population. Hypertension 1995, 25, 305–313. [Google Scholar] [CrossRef] [PubMed]
- Lima, R.; Wofford, M.; Reckelhoff, J.F. Hypertension in Postmenopausal Women. Curr. Hypertens. Rev. 2012, 14, 254–260. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Neupane, D.; Mclachlan, C.S.; Sharma, R.; Gyawali, B.; Khanal, V.; Mishra, S.R.; Christensen, B.; Kallestrup, P. Prevalence of Hypertension in Member Countries of South Asian Association for Regional Cooperation (SAARC). Medicine 2014, 93, e74. [Google Scholar] [CrossRef]
- Jesmin, S.; Rahman, M.A.; Akter, S.; Islam, M.; Khatun, T.; Sultana, S.N.; Sayeedaa, N.; Zaedi, S.; Okazaki, O.; Iwashima, Y.; et al. Assessment of Hypertension and the Associated Risk Factors in Postmenopausal Rural Women in Bangladesh. J. Hypertens. 2015, 33. [Google Scholar] [CrossRef]
- Zaman, M.; Rahman, M.M.; Rahman, M.R.; Bhuiyan, M.; Karim, M.N.; Chowdhury, M.A. Prevalence of risk factors for non-communicable diseases in Bangladesh: Results from STEPS survey 2010. Indian J. Public Health 2016, 60, 17. [Google Scholar] [CrossRef] [PubMed]
- Whelton, P.K.; Carey, R.M.; Aronow, W.S.; Casey, D.E., Jr.; Collins, K.J.; Himmelfarb, C.D.; DePalma, S.M.; Gidding, S.; Jamerson, K.A.; Jones, D.W.; et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018, 71. [Google Scholar] [CrossRef]
- Islam, J.Y.; Zaman, M.M.; Haq, S.A.; Ahmed, S.; Quadir, Z.A. Epidemiology of hypertension among Bangladeshi adults using the 2017 ACC/AHA Hypertension Clinical Practice Guidelines and Joint National Committee 7 Guidelines. J. Hum. Hypertens. 2018, 32, 668–680. [Google Scholar] [CrossRef]
- Kibria, G.M.A.; Swasey, K.; Kc, A.; Mirbolouk, M.; Sakib, M.N.; Sharmeen, A.; Chadni, M.J.; Stafford, K.A. Estimated Change in Prevalence of Hypertension in Nepal Following Application of the 2017 ACC/AHA Guideline. JAMA Netw. Open 2018, 1, e180606. [Google Scholar] [CrossRef]
- Watkins, D.A. Implications of the 2017 ACC/AHA Hypertension Guideline for Public Health in Nepal. JAMA Netw. Open 2018, 1. [Google Scholar] [CrossRef]
- Narang, R.; Srikant, S. Implications of 2017 hypertension guidelines for Indian patients. J. Pract. Cardiovasc. Sc. 2018, 4, 3. [Google Scholar] [CrossRef]
- Awotidebe, T. Cardiovascular Risk Profile of Post-Menopausal Women in a Semi-Urban Community in Nigeria. Br. J. Med. Med. Res. 2014, 4, 4780–4790. [Google Scholar] [CrossRef]
- Soules, M.R.; Sherman, S.; Parrott, E.; Rebar, R.; Santoro, N.; Utian, W.; Woods, N. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Climacteric 2001, 4, 267–272. [Google Scholar] [CrossRef]
- Bonita, R. Surveillance of Risk Factors for Noncommunicable Diseases: The WHO STEPwise Approach: Summary; Noncommunicable Disease and Mental Health, World Health Organization: Geneva, Switzerland, 2001. [Google Scholar]
- Gerrior, S.; Juan, W.Y.; Peter, B. An Easy Approach to Calculating Estimated Energy Requirements. Prev. Chronic Dis. 2006, 3. [Google Scholar]
- Non-Communicable Disease Risk Factor Survey Bangladesh 2010. Available online: https://www.who.int/ncds/surveillance/steps/2010_STEPS_Report_Bangladesh.pdf (accessed on 8 May 2019).
- Friedewald, W.T.; Levy, R.I.; Fredrickson, D.S. Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge. Clin. Chem. 1972, 18, 499–502. [Google Scholar] [PubMed]
- Byrt, T.; Bishop, J.; Carlin, J.B. Bias, prevalence and kappa. J. Clin. Epidemiol. 1993, 46, 423–429. [Google Scholar] [CrossRef]
- Xie, Q. Agree or Disagree? A Demonstration of an Alternative Statistic to Cohen’s Kappa for Measuring the Extent and Reliability of Agreement between Observers. Paper Presented at FCSM Research Conference, Washington, DC, USA, 7–9 November 2013. [Google Scholar]
- Cicchetti, D.V.; Feinstein, A.R. High agreement but low kappa: II. Resolving the paradoxes. J. Clin. Epidemiol. 1990, 43, 551–558. [Google Scholar] [CrossRef]
- Landis, J.R.; Koch, G.G. The Measurement of Observer Agreement for Categorical Data. Biometrics 1977, 33, 159. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kibria, G.M.A.; Swasey, K.; Choudhury, A.; Burrowes, V.; Stafford, K.A.; Uddin, S.M.I.; Mirbolouk, M.; Sharmeen, A.; Kc, A.; Mitra, D.K. The new 2017 ACC/AHA guideline for classification of hypertension: Changes in prevalence of hypertension among adults in Bangladesh. J. Hum. Hypertens. 2018, 32, 608–616. [Google Scholar] [CrossRef] [PubMed]
- Estrogen Deficiency Can Lead To Obesity-induced High Blood Pressure After Menopause, Study Suggests. ScienceDaily. 2007. Available online: https://www.sciencedaily.com/releases/2007/08/070808171003.htm (accessed on 8 May 2019).
- Khera, R.; Lu, Y.; Lu, J.; Saxena, A.; Nasir, K.; Jiang, L.; Krumholz, H.M. Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: Nationally representative cross sectional study. BMJ 2018, 362, k2357. [Google Scholar] [CrossRef] [PubMed]
- Tadic, M.; Cuspidi, C. Does the change of hypertension guidelines actually affect our reality? Ann. Transl. Med. 2018, 6, 373. [Google Scholar] [CrossRef] [PubMed]
- Muntner, P.; Carey, R.M.; Gidding, S.; Jones, D.W.; Taler, S.J.; Wright, J.T.; Whelton, P.K. Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline. Circulation 2018, 137, 109–118. [Google Scholar] [CrossRef] [PubMed]
- Understanding Blood Pressure Readings. About Heart Attacks. Available online: https://www.heart.org/en/health-topics/high-blood-pressure/understanding-blood-pressure-readings (accessed on 11 February 2019).
- Chobanian, A.V. Isolated Systolic Hypertension in the Elderly. N. Engl. J. Med. 2007, 357, 789–796. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Guo, X.; Zhang, X.; Guo, L.; Li, Z.; Zheng, L.; Yu, S.; Yang, H.; Zhou, X.; Zhang, X.; Sun, Z.; et al. Association Between Pre-hypertension and Cardiovascular Outcomes: A Systematic Review and Meta-analysis of Prospective Studies. Curr. Hypertens. Rep. 2013, 15, 703–716. [Google Scholar] [CrossRef] [PubMed]
- Sim, J.; Wright, C. The Kappa Statistic in Reliability Studies: Use, Interpretation, and Sample Size Requirements. Phys.Ther. 2005. [Google Scholar] [CrossRef]
- Franklin, S.S.; Larson, M.G.; Khan, S.A.; Wong, N.D.; Leip, E.P.; Kannel, W.B.; Levy, D. Does the Relation of Blood Pressure to Coronary Heart Disease Risk Change with Aging? Circulation 2001, 103, 1245–1249. [Google Scholar] [CrossRef]
- Neaton, J.D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. Arch. Intern. Med. 1992, 152, 56–64. [Google Scholar] [CrossRef]
- The SPRINT Research Group. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N. Engl. J. Med. 2015, 373, 2103–2116. [Google Scholar] [CrossRef]
- Mancia, G.; Seravalle, G.; Grassi, G. Systolic blood pressure: an underestimated cardiovascular risk factor. J. Hypertens. 2002, 20, S21–S27. [Google Scholar]
Variables | n (%) |
---|---|
Hypertension sub-types | |
JNC 7 | |
Isolated systolic hypertension | 76 (28.7) |
Isolated diastolic hypertension | 57 (21.5) |
Systolic and/diastolic hypertension * | 111 (41.9) |
2017 ACC/AHA | |
Isolated systolic hypertension | 113 (42.6) |
Isolated diastolic hypertension | 152 (57.4) |
Systolic and/diastolic hypertension * | 179 (67.5) |
Hypertension staging | |
JNC 7 | |
Pre-hypertension | 86 (32.5) |
Stage 1 | 76 (28.7) |
Stage 2 | 18 (6.8) |
2017 ACC/AHA | |
Elevated blood pressure | 10 (3.8) |
Stage 1 | 76 (28.7) |
Stage 2 | 95 (35.8) |
HTN Sub-Types/Staging | JNC 7 Classification | ACC/AHA Classification | κ | BI | PI | PABAK | AC1 | |
---|---|---|---|---|---|---|---|---|
Yes | No | |||||||
Isolated systolic HTN | Yes, n=76 | 76 | 0 | 0.74 (0.66–0.82) | −0.14 (−0.23 to −0.06) | −0.29 (−0.37 to −0.21) | 0.76 (0.68–0.84) | 0.84 (0.76–0.92) |
No, n = 189 | 37 | 152 | ||||||
Total, n = 265 | 113 | 152 | ||||||
Observed agreement, p0 | 86.03 (81.8–90.2) | |||||||
p-value | <0.001 | |||||||
Isolated diastolic HTN | Yes, n = 57 | 57 | 0 | 0.5 (0.35–0.65) | −0.36 (−0.46 to −0.26) | −0.21 (−0.31 to −0.11) | 0.28 (0.18–0.38) | 0.32 (0.22–0.42) |
No, n = 208 | 95 | 113 | ||||||
Total, n = 265 | 152 | 113 | ||||||
Observed agreement, p0 | 64.2 (58.4–70) | |||||||
p-value | <0.001 | |||||||
Combined systolic and/diastolic HTN | Yes, n = 111 | 111 | 0 | 0.51 (0.41–0.61) | −0.26 (−0.36 to −0.16) | −0.09 (−0.19–0.01) | 0.48 (0.38–0.58) | 0.49 (0.39–0.59) |
No, n = 154 | 68 | 86 | ||||||
Total, n = 265 | 179 | 86 | ||||||
Observed agreement, p0 | 74.3 (58.4–70) | |||||||
p-value | <0.001 | |||||||
Pre-HTN/elevated BP | Yes, n = 86 | 10 | 76 | 0.12 (−0.04–0.28) | 0.29(0.13–0.45) | −0.64 (−0.80 to −0.48) | 0.42(0.26–0.58) | 0.83 (0.67–0.99) |
No, n = 179 | 0 | 179 | ||||||
Total, n = 265 | 10 | 255 | ||||||
Observed agreement, p0 | 71.3 (65.9–76.7) | |||||||
p-value | <0.001 | |||||||
Stage 1 HTN | Yes, n = 76 | 0 | 76 | −0.39 (−0.49 to −0.29) | 0 | −0.43 (−0.53 to −0.33) | −0.16 (−0.26 to −0.06) | −0.35 (−0.45 to −0.25) |
No, n = 189 | 76 | 113 | ||||||
Total, n = 265 | 76 | 189 | ||||||
Observed agreement, p0 | 42.6 (36.6–48.6) | |||||||
p-value | <0.001 | |||||||
Stage 2 HTN | Yes, n = 18 | 18 | 0 | 0.24 (0.10–0.38) | −0.29 (−0.43 to −0.15) | −0.57 (−0.71 to −0.43) | 0.42 (0.28–0.56) | 0.75 (0.61–0.89) |
No, n = 247 | 77 | 170 | ||||||
Total, n = 265 | 95 | 170 | ||||||
Observed agreement, p0 | 70.9 (65.4–76.2) | |||||||
p-value | <0.001 |
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Barua, L.; Faruque, M.; Banik, P.C.; Ali, L. Agreement between 2017 ACC/AHA Hypertension Clinical Practice Guidelines and Seventh Report of the Joint National Committee Guidelines to Estimate Prevalence of Postmenopausal Hypertension in a Rural Area of Bangladesh: A Cross Sectional Study. Medicina 2019, 55, 315. https://doi.org/10.3390/medicina55070315
Barua L, Faruque M, Banik PC, Ali L. Agreement between 2017 ACC/AHA Hypertension Clinical Practice Guidelines and Seventh Report of the Joint National Committee Guidelines to Estimate Prevalence of Postmenopausal Hypertension in a Rural Area of Bangladesh: A Cross Sectional Study. Medicina. 2019; 55(7):315. https://doi.org/10.3390/medicina55070315
Chicago/Turabian StyleBarua, Lingkan, Mithila Faruque, Palash Chandra Banik, and Liaquat Ali. 2019. "Agreement between 2017 ACC/AHA Hypertension Clinical Practice Guidelines and Seventh Report of the Joint National Committee Guidelines to Estimate Prevalence of Postmenopausal Hypertension in a Rural Area of Bangladesh: A Cross Sectional Study" Medicina 55, no. 7: 315. https://doi.org/10.3390/medicina55070315